NEW YORK (AVAFIN) -- Arena Pharmaceuticals options contracts experienced a new 90-day record for call contracts where a total
of 12,529 call contracts were traded in the busy trading session. The contract spread
yielded a 0.74 put/call ratio where 1.4 call contracts were traded for each put contract.
Investors use options to manage risk and to speculate on price changes. Options can provide
significant leverage if the stock moves in the right direction but aslo end up worthless if it
doesn't.
Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative therapies offering medical advances and new options for patients.
Arena Pharmaceuticals opened at $8.36 and the stock price declined $0.04 (0.48%)
to $8.31 during the market session. ARNA is trading between the range of
$8.31 - $8.45. Performance indicators show that the stock has lost -20.10% within the last month.
Volume is 3M in relation to the three month
average volume of 8M shares. ARNA is trading below the 50
day moving average and lower than the 200 day moving average.
